TREATMENT OF PRIMARY SJÖGREN'S SYNDROME BY INHIBITING FCRN: A PHASE 2 RANDOMIZED, PLACEBO CONTROLLED, DOUBLE-BLIND, PROOF OF CONCEPT STUDY WITH EFGARTIGIMOD.

Details

Language :

English

ISSN :

00034967

Volume :

82

Database :

Complementary Index

Journal :

Annals of the Rheumatic Diseases

Publication Type :

Academic Journal

Accession number :

164386550

Full Text :

https://doi.org/10.1136/annrheumdis-2023-eular.3188